Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
EVH
|
Seth Blackley
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,285 Reduced 1.96% |
$144,809
$27.4 p/Share
|
Mar 01
2022 |
|
EVH
|
Seth Blackley
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 64,991 Added 19.41% |
-
|
Mar 01
2022 |
|
EVH
|
Aammaad Shams
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,613 Reduced 7.59% |
$44,196
$27.4 p/Share
|
Mar 01
2022 |
|
EVH
|
Aammaad Shams
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 6,250 Added 22.73% |
-
|
Mar 01
2022 |
|
EVH
|
John Paul Johnson
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,510 Reduced 2.8% |
$123,574
$27.4 p/Share
|
Mar 01
2022 |
|
EVH
|
John Paul Johnson
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 24,000 Added 12.98% |
-
|
Mar 01
2022 |
|
KNBE
|
Kevin Klausmeyer
Director |
SELL
Open market or private sale
|
Direct | 11,616 Reduced 100.0% |
$239,870
$20.65 p/Share
|
Mar 01
2022 |
|
KNBE
|
Kevin Klausmeyer
Director |
BUY
Conversion of derivative security
|
Direct | 11,616 Added 50.0% |
-
|
Mar 01
2022 |
|
COOP
|
Eldridge A Burns
EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct | 6,886 Added 19.12% |
-
|
Mar 01
2022 |
|
COOP
|
Eldridge A Burns
EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,161 Reduced 4.96% |
$59,014
$50.83 p/Share
|
Mar 01
2022 |
|
COOP
|
Jesse K Bray
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 68,857 Added 5.89% |
-
|
Mar 01
2022 |
|
COOP
|
Jesse K Bray
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 101,865 Reduced 8.99% |
$5,077,970
$49.85 p/Share
|
Mar 01
2022 |
|
COOP
|
Michael R Rawls
EVP & CEO-Xome |
BUY
Grant, award, or other acquisition
|
Direct | 22,783 Added 15.55% |
-
|
Mar 01
2022 |
|
COOP
|
Michael R Rawls
EVP & CEO-Xome |
SELL
Payment of exercise price or tax liability
|
Direct | 17,744 Reduced 14.94% |
$893,233
$50.34 p/Share
|
Mar 01
2022 |
|
COOP
|
Christopher G Marshall
Vice Chairman & President |
BUY
Grant, award, or other acquisition
|
Direct | 39,347 Added 5.17% |
-
|
Mar 01
2022 |
|
COOP
|
Christopher G Marshall
Vice Chairman & President |
SELL
Payment of exercise price or tax liability
|
Direct | 51,755 Reduced 7.06% |
$2,579,987
$49.85 p/Share
|
Mar 01
2022 |
|
COOP
|
Kurt G Johnson
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,837 Added 14.63% |
-
|
Mar 01
2022 |
|
COOP
|
Kurt G Johnson
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,640 Reduced 7.11% |
$183,238
$50.34 p/Share
|
Mar 01
2022 |
|
CNMD
|
Todd W Garner
Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 469 Reduced 15.83% |
$67,794
$144.55 p/Share
|
Mar 01
2022 |
|
CNMD
|
Todd W Garner
Executive Vice President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,600 Added 35.06% |
-
|
Mar 01
2022 |
|
CNMD
|
John Jed Kennedy
Group Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 1,070 Reduced 9.79% |
$154,669
$144.55 p/Share
|
Mar 01
2022 |
|
CNMD
|
John Jed Kennedy
Group Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 3,550 Added 25.89% |
-
|
Mar 01
2022 |
|
CVET
|
Benjamin Wolin
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 111,240 Added 27.51% |
-
|
Mar 01
2022 |
|
CVET
|
Benjamin Wolin
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 29,664 Added 14.02% |
-
|
Mar 01
2022 |
|
CVET
|
Benjamin Wolin
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 53,456 Reduced 18.24% |
$954,190
$17.85 p/Share
|
Mar 01
2022 |
|
CVET
|
Matthew Malenfant
Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 17,507 Added 24.11% |
-
|
Mar 01
2022 |
|
CVET
|
Matthew Malenfant
Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 6,472 Added 14.68% |
-
|
Mar 01
2022 |
|
CVET
|
Matthew Malenfant
Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,702 Reduced 12.16% |
$119,631
$17.85 p/Share
|
Mar 01
2022 |
|
CVET
|
Georgina Wraight
Officer |
BUY
Grant, award, or other acquisition
|
Direct | 35,353 Added 26.6% |
-
|
Mar 01
2022 |
|
CVET
|
Georgina Wraight
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 6,472 Added 9.42% |
-
|
Mar 01
2022 |
|
CVET
|
Georgina Wraight
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 14,215 Reduced 14.57% |
$253,738
$17.85 p/Share
|
Mar 01
2022 |
|
CVET
|
Matthew J. Foulston
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 20,740 Added 21.99% |
-
|
Mar 01
2022 |
|
CVET
|
Matthew J. Foulston
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 10,247 Added 16.24% |
-
|
Mar 01
2022 |
|
CVET
|
Matthew J. Foulston
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 7,617 Reduced 10.35% |
$135,963
$17.85 p/Share
|
Mar 01
2022 |
|
CVET
|
Dustin Finer
Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct | 35,353 Added 25.85% |
-
|
Mar 01
2022 |
|
CVET
|
Dustin Finer
Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 5,393 Added 7.55% |
-
|
Mar 01
2022 |
|
CVET
|
Dustin Finer
Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 12,814 Reduced 12.63% |
$228,730
$17.85 p/Share
|
Mar 01
2022 |
|
MGEE
|
James L Possin |
BUY
Open market or private purchase
|
Direct | 400 Added 25.0% |
$28,020
$70.05 p/Share
|
Mar 01
2022 |
|
BPMC
|
Jeffrey W. Albers |
BUY
Grant, award, or other acquisition
|
Direct | 7,500 Added 3.69% |
-
|
Mar 01
2022 |
|
BPMC
|
Fouad Namouni
PRESIDENT, R & D |
BUY
Grant, award, or other acquisition
|
Direct | 15,000 Added 20.74% |
-
|
Mar 01
2022 |
|
BPMC
|
Christopher K. Murray
CHIEF TECHNICAL OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct | 6,500 Added 20.38% |
-
|
Mar 01
2022 |
|
BPMC
|
Tracey L Mc Cain
EVP AND CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 12,500 Added 21.39% |
-
|
Mar 01
2022 |
|
BPMC
|
Michael Landsittel
CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 12,500 Added 23.19% |
-
|
Mar 01
2022 |
|
BPMC
|
L. Becker Hewes
CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 8,750 Added 20.03% |
-
|
Mar 01
2022 |
|
BPMC
|
Kate Haviland
CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 40,000 Added 29.86% |
-
|
Mar 01
2022 |
|
BPMC
|
Percy H. Carter
CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 8,750 Added 22.24% |
-
|
Mar 01
2022 |
|
BPMC
|
Christina Rossi
CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 15,000 Added 24.3% |
-
|
Mar 01
2022 |
|
BPMC
|
Debra Durso Bumpus
CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 12,500 Added 22.37% |
-
|
Mar 01
2022 |
|
BPMC
|
Ariel Hurley
PRINCIPAL ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 2,875 Added 18.14% |
-
|
Mar 01
2022 |
|
SITM
|
Fariborz Assaderaghi
Officer |
SELL
Open market or private sale
|
Direct | 2,837 Reduced 2.18% |
$550,378
$194.0 p/Share
|
Mar 01
2022 |